Vitamin D Supplementation in Glomerular Disease

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Glomerular Disease
Interventions
DIETARY_SUPPLEMENT

Cholecalciferol, 2000 or 4000 IUs by mouth daily for 12 weeks

Supplements will be provided as oral capsules.

Trial Locations (5)

11040

North Shore-Long Island Jewish Health System, New Hyde Park

19104

Children's Hospital of Philadelphia, Philadelphia

The Hospital of the University of Pennsylvania, Philadelphia

19803

Nemours/Alfred I. duPont Hospital for Children, Wilmington

21287

Johns Hopkins University,Division of Pediatric Nephrology, Baltimore

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

American Society of Nephrology

OTHER

collaborator

The NephCure Foundation

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT01835639 - Vitamin D Supplementation in Glomerular Disease | Biotech Hunter | Biotech Hunter